Sexcord/ stromal ovarian tumors screening
|
Sexcord/ stromal ovarian tumors Microchapters |
|
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sexcord/ stromal ovarian tumors screening On the Web |
|
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors screening |
|
Risk calculators and risk factors for Sexcord/ stromal ovarian tumors screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- The US Preventive Services Task Force(USPSTF) recommends against screening for ovarian cancer in asymptomatic women[1][2]
- The USPSTF found that screening with either transvaginal ultrasound or testing for the serum tumor marker cancer antigen 125 (CA-125) or a combination of both does not reduce ovarian cancer mortality
References
- ↑ Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen (2018). "Screening for Ovarian Cancer". JAMA. 319 (6): 588. doi:10.1001/jama.2017.21926. ISSN 0098-7484.
- ↑ Henderson, Jillian T.; Webber, Elizabeth M.; Sawaya, George F. (2018). "Screening for Ovarian Cancer". JAMA. 319 (6): 595. doi:10.1001/jama.2017.21421. ISSN 0098-7484.